Literature DB >> 12757928

Generation of recombinant influenza virus using baculovirus delivery vector.

Kanokwan Poomputsa1, Christian Kittel, Andrej Egorov, Wolfgang Ernst, Reingard Grabherr.   

Abstract

A recombinant baculovirus vector containing mammalian cell-active promoters and transcription terminators was used to deliver a mutated influenza NS gene into Vero cells. In addition to the influenza NS gene, the baculovirus contained a reporter gene expression cassette (Green fluorescent protein, GFP), allowing to monitor the Vero cell transduction efficiency. More than 90% of Vero cells were expressing GFP 24-48 h post transduction. After infecting baculovirus transduced cells with influenza helper virus, progeny of attenuated influenza virus carrying the recombinant NS gene could be selected. Baculovirus delivery was highly reproducible and efficient in Vero cells. This new method for influenza gene delivery could contribute to influenza virus research and vaccine development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757928     DOI: 10.1016/s0166-0934(03)00084-3

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge.

Authors:  Sabine Sereinig; Marina Stukova; Natalia Zabolotnyh; Boris Ferko; Christian Kittel; Julia Romanova; Tatiana Vinogradova; Hermann Katinger; Oleg Kiselev; Andrej Egorov
Journal:  Clin Vaccine Immunol       Date:  2006-08

2.  Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.

Authors:  Christian Kittel; Boris Ferko; Martina Kurz; Regina Voglauer; Sabine Sereinig; Julia Romanova; Gabriela Stiegler; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 3.  Many ways to make an influenza virus--review of influenza virus reverse genetics methods.

Authors:  Othmar G Engelhardt
Journal:  Influenza Other Respir Viruses       Date:  2012-06-19       Impact factor: 4.380

Review 4.  Baculovirus vectors for gene therapy.

Authors:  Yu-Chen Hu
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

Review 5.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.